rs10797724

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001205293.3(CACNA1E):​c.513-28777A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.733 in 152,120 control chromosomes in the GnomAD database, including 43,234 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.73 ( 43234 hom., cov: 32)

Consequence

CACNA1E
NM_001205293.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.413

Publications

5 publications found
Variant links:
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CACNA1E Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 69
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neurodevelopmental disorder
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.863 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001205293.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1E
NM_001205293.3
MANE Select
c.513-28777A>G
intron
N/ANP_001192222.1
CACNA1E
NM_000721.4
c.513-28777A>G
intron
N/ANP_000712.2
CACNA1E
NM_001205294.2
c.513-28777A>G
intron
N/ANP_001192223.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1E
ENST00000367573.7
TSL:1 MANE Select
c.513-28777A>G
intron
N/AENSP00000356545.2
CACNA1E
ENST00000360108.7
TSL:5
c.513-28777A>G
intron
N/AENSP00000353222.3
CACNA1E
ENST00000367570.6
TSL:1
c.513-28777A>G
intron
N/AENSP00000356542.1

Frequencies

GnomAD3 genomes
AF:
0.733
AC:
111439
AN:
152002
Hom.:
43225
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.460
Gnomad AMI
AF:
0.939
Gnomad AMR
AF:
0.752
Gnomad ASJ
AF:
0.806
Gnomad EAS
AF:
0.742
Gnomad SAS
AF:
0.717
Gnomad FIN
AF:
0.861
Gnomad MID
AF:
0.775
Gnomad NFE
AF:
0.868
Gnomad OTH
AF:
0.755
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.733
AC:
111476
AN:
152120
Hom.:
43234
Cov.:
32
AF XY:
0.733
AC XY:
54521
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.459
AC:
19035
AN:
41452
American (AMR)
AF:
0.752
AC:
11485
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.806
AC:
2794
AN:
3468
East Asian (EAS)
AF:
0.742
AC:
3841
AN:
5176
South Asian (SAS)
AF:
0.718
AC:
3466
AN:
4826
European-Finnish (FIN)
AF:
0.861
AC:
9118
AN:
10588
Middle Eastern (MID)
AF:
0.779
AC:
229
AN:
294
European-Non Finnish (NFE)
AF:
0.868
AC:
59060
AN:
68012
Other (OTH)
AF:
0.755
AC:
1592
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1299
2598
3897
5196
6495
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
832
1664
2496
3328
4160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.829
Hom.:
40205
Bravo
AF:
0.713
Asia WGS
AF:
0.734
AC:
2556
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
6.0
DANN
Benign
0.66
PhyloP100
0.41
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10797724; hg19: chr1-181518125; API